Cibus, Inc. (CBUS) vs Nutriband Inc. (NTRB)

Cibus, Inc. and Nutriband Inc. are both Biotechnology companies. Cibus, Inc. and Nutriband Inc. are of similar size ($115.2M and $114.6M). Cibus, Inc. grew revenue faster over the last twelve months: −10.3% against −37.3%. Nutriband Inc. has the higher net margin (−430.4% vs −2,258.9%) and the lower return on invested capital (−227.9% vs 0.00%). Across the 18 metrics below, Cibus, Inc. leads on 10 and Nutriband Inc. on 8.

Valuation

Metric CBUS NTRB Biotechnology median
P/E n/m n/m 7.88
P/S 27.02 60.12 11.47
P/B 7.93 18.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.56 58.11 10.73
Earnings yield (107.84%) (7.16%) (28.84%)
Free cash flow yield (39.41%) (3.74%) (23.03%)

Profitability

Metric CBUS NTRB Biotechnology median
Gross margin 100.00% 33.14% 65.16%
Operating margin (1,450.59%) (435.57%) 0.00%
Net margin (2,258.89%) (430.43%) 0.00%
Free cash flow margin (1,064.60%) (224.54%) 0.00%
Return on equity (219.97%) (100.79%) (57.72%)
Return on assets (29.77%) (84.56%) (49.22%)
Return on invested capital 0.00% (227.92%) 0.00%

Growth

Metric CBUS NTRB Biotechnology median
Revenue growth (TTM) (10.30%) (37.25%) 5.64%
EPS growth (last fiscal year) 74.33% (160.61%) —
Revenue growth, 5-year CAGR (31.34%) 16.63% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS NTRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 4.21 4.73
Net debt to EBITDA (0.28) 0.56 0.96

Dividend

Metric CBUS NTRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CBUS NTRB Biotechnology median
Market cap 114.64m 115.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack